Skip to main content
Retour
RVMD logo

Revolution Medicines, Inc.

Qualité des données : 100%
RVMD
NASDAQ Healthcare Biotechnology
96,63 €
▲ 0,85 € (0,89%)
Cap. Boursière : 19,15B
Fourchette du Jour
96,14 € 98,80 €
Fourchette 52 Semaines
29,17 € 124,49 €
Volume
1 366 459
Moyenne 50J / 200J
103,15 € / 64,57 €
Clôture Précédente
95,78 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (626 pairs)

Métrique Action Médiane du Secteur
P/E -16,9 0,4
P/B 11,7 2,9
ROE % -58,1 3,7
Net Margin % 3,8
Rev Growth 5Y % 10,0
D/E 0,1 0,2

Points Clés

Debt/Equity of 0,10 — conservative balance sheet
Negative free cash flow of -913,73M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-58,07%
ROIC-49,54%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
0,10
Current Ratio7,14
Interest Coverage-48,80

Valorisation

P/E Ratio
-16,93
P/B Ratio11,74
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -1,13B
ROE -58,07% ROA -48,05%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -913,73M
ROIC -49,54% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,10 Current Ratio 7,14
Interest Coverage -48,80 Dividend Yield 0,00%
Valuation
P/E Ratio -16,93 P/B Ratio 11,74
P/S Ratio N/A PEG Ratio -0,20
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 19,15B Enterprise Value 18,92B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0,0 0,0 11,58M 35,38M 29,39M
Net Income -1,13B -600,09M -436,37M -248,71M -187,09M
EPS (Diluted) -5,95 -3,58 -3,86 -3,08 -2,47
Gross Profit -16,56M 0,0 11,58M 35,38M 29,39M
Operating Income -1,18B -689,52M -487,19M -258,28M -188,01M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2,35B 2,56B 2,06B 811,93M 737,99M
Total Liabilities 723,21M 293,10M 235,51M 126,74M 135,42M
Shareholders' Equity 1,63B 2,27B 1,83B 685,19M 602,57M
Total Debt 158,70M 135,84M 87,94M 64,21M 66,63M
Cash & Equivalents 383,75M 543,06M 696,15M 161,41M 108,50M
Current Assets 2,08B 2,33B 1,88B 660,19M 589,77M
Current Liabilities 290,42M 163,91M 143,85M 61,98M 60,35M